(4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine

C47H43F6N11O2 — CID 162252775

IUPAC(4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine
SMILESCOc1nc(-c2cc3n(n2)CCC[C@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1.COc1nc(-c2nc3n(n2)CCC[C@@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1
InChIInChI=1S/C24H22F3N5O.C23H21F3N6O/c1-15-13-31(14-28-15)21-10-9-19(29-23(21)33-2)20-12-22-17(7-5-11-32(22)30-20)16-6-3-4-8-18(16)24(25,26)27;1-14-12-31(13-27-14)19-10-9-18(28-22(19)33-2)20-29-21-16(7-5-11-32(21)30-20)15-6-3-4-8-17(15)23(24,25)26/h3-4,6,8-10,12-14,17H,5,7,11H2,1-2H3;3-4,6,8-10,12-13,16H,5,7,11H2,1-2H3/t17-;16-/m01/s1
InChIKeyZYEYYKYHSLAWNT-FPNZUHJHSA-N
MW907.92 g/mol
LogP10.18
Rot. Bonds8

About (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine

(4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine (PubChem CID 162252775) has the molecular formula C47H43F6N11O2 and a molecular weight of 907.92 g/mol. Its IUPAC name is (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine.

Molecular Properties

Compound Name(4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine
PubChem CID162252775
Molecular FormulaC47H43F6N11O2
Molecular Weight907.92 g/mol
Exact Mass907.35
IUPAC Name(4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine
SMILESCOc1nc(-c2cc3n(n2)CCC[C@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1.COc1nc(-c2nc3n(n2)CCC[C@@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1
InChIInChI=1S/C24H22F3N5O.C23H21F3N6O/c1-15-13-31(14-28-15)21-10-9-19(29-23(21)33-2)20-12-22-17(7-5-11-32(22)30-20)16-6-3-4-8-18(16)24(25,26)27;1-14-12-31(13-27-14)19-10-9-18(28-22(19)33-2)20-29-21-16(7-5-11-32(21)30-20)15-6-3-4-8-17(15)23(24,25)26/h3-4,6,8-10,12-14,17H,5,7,11H2,1-2H3;3-4,6,8-10,12-13,16H,5,7,11H2,1-2H3/t17-;16-/m01/s1
InChIKeyZYEYYKYHSLAWNT-FPNZUHJHSA-N
XLogP10.18
TPSA128.41 Ų
H-Bond Donors
H-Bond Acceptors13
Rotatable Bonds8
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500907.92
LogP ≤ 510.18
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1013

Analyze (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
The IUPAC name of (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine (CID 162252775) is (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine.
What is the SMILES notation for (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
The canonical SMILES for (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine is COc1nc(-c2cc3n(n2)CCC[C@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1.COc1nc(-c2nc3n(n2)CCC[C@@H]3c2ccccc2C(F)(F)F)ccc1-n1cnc(C)c1.
What is the InChIKey of (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
The InChIKey is ZYEYYKYHSLAWNT-FPNZUHJHSA-N. The full InChI is InChI=1S/C24H22F3N5O.C23H21F3N6O/c1-15-13-31(14-28-15)21-10-9-19(29-23(21)33-2)20-12-22-17(7-5-11-32(22)30-20)16-6-3-4-8-18(16)24(25,26)27;1-14-12-31(13-27-14)19-10-9-18(28-22(19)33-2)20-29-21-16(7-5-11-32(21)30-20)15-6-3-4-8-17(15)23(24,25)26/h3-4,6,8-10,12-14,17H,5,7,11H2,1-2H3;3-4,6,8-10,12-13,16H,5,7,11H2,1-2H3/t17-;16-/m01/s1.
What are the key properties of (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
(4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine has a molecular weight of 907.92 g/mol, XLogP of 10.18, 8 rotatable bonds, 0 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (4S)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-[2-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine;(8R)-2-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-8-[2-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine is sourced from PubChem (CID 162252775), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).